Evidence map›Paper›PMID 36127717›Full record

ArticleBMC health services research2022

Long-term care, care needs and wellbeing of individuals after cancer in childhood or adolescence (VersKiK): study protocol of a large scale multi-methods non-interventional study.

E Aleshchenko, E Swart, C Spix, M Voigt, P Trocchi, T Langer, G Calaminus, K Baust, J Glogner, P Ihle and 10 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 1 country.

E AleshchenkoInstitute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto Von Guericke Univiersity, Magdeburg, Germany. ekaterina.aleshchenko@med.ovgu.de.
E SwartInstitute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto Von Guericke Univiersity, Magdeburg, Germany.
C SpixDivision of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
M VoigtDivision of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
P TrocchiInstitute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto Von Guericke Univiersity, Magdeburg, Germany.
T LangerUniversity Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
G CalaminusDepartment of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
K BaustDepartment of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
J GlognerDepartment of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
P IhlePMV Research Group at the Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, University of Cologne, Köln, Germany.
J Küpper-NybelenPMV Research Group at the Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, University of Cologne, Köln, Germany.
C LüpkesOFFIS-Institute for Information Technology, Oldenburg, Germany.
T KloppeOFFIS-Institute for Information Technology, Oldenburg, Germany.
D Horenkamp-SonntagTechniker Krankenkasse (TK), Hamburg, Germany.
I MeierTechniker Krankenkasse (TK), Hamburg, Germany.
U MarschallBARMER, Wuppertal, Germany.
P DrögeAOK Research Institute (WIdO), Berlin, Germany.
M KleinDAK-Gesundheit, Hamburg, Germany.
A WeissMedical Sociology, Institute for Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
C ApfelbacherInstitute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto Von Guericke Univiersity, Magdeburg, Germany.
Otto-von-Guericke-Universität Magdeburg · DEUniversity Hospital Bonn · DEJohannes Gutenberg University Mainz · DEOldenburger Institut für Informatik · DETechniker Krankenkasse (Germany) · DEUniversity of Cologne · DEBARMER GEK · DEDAK-Gesundheit (Germany) · DEUniversity Hospital Schleswig-Holstein · DEUniversity of Regensburg · DEWissenschaftliches Institut der AOK · DE

Funding

Gemeinsame Bundesausschuss 01VSF19013
6 · The paper itself

Abstract

backgroundIt has been shown previously that a relevant proportion of childhood cancer survivors suffers from late effects, which are often directly related to the cancer itself or its therapy, resulting in particular follow-up needs, additionally burdening healthcare systems. Being diagnosed with cancer at a vulnerable stage of development, this group of cancer survivors is at comparatively higher risk of relapse or subsequent cancer. Although national and international follow-up guidelines based on treatment modalities have been developed, their implementation seems to leave room for improvement. Additionally, they lack a sufficient consideration of the survivors' psychosocial needs, affecting their adherence to them. The aim of the VersKiK study is to provide representative information on late effects in childhood and adolescence cancer survivors in Germany. The main research objectives are: (1) to describe the state of follow-up care among survivors after a cancer diagnosis in childhood or adolescence; (2) to quantify the occurrence of late effects among this group of survivors; (3) to examine the adherence to selected audiological and cardiological follow-up guidelines and to identify factors affecting it; (4) to explore actual follow-up needs of paediatric cancer survivors; (5) to review selected follow-up guidelines with the aim to improve and expand them.

methodsVersKiK is designed as a mixed-methods non-interventional study. We will use claims data from statutory health insurance companies in combination with individually linked population-based registry data from the German Childhood Cancer Registry (GCCR). This data base will permit us to quantify diagnoses and procedures in comparison to the general population as well as the adherence to existing follow-up guidelines. Additional information will be obtained through interviews with childhood and adolescence cancer survivors and their informal caregivers, as well as in focus groups with healthcare professionals. DISCUSSION: The present study aims to research the actual needs of individuals after cancer diagnosis and treatment in childhood or adolescence - physical, psychological and organisational - in order to improve existing follow-up guidelines. These improvements might further positively affect not only actual care provided to paediatric cancer survivors, but also benefit healthcare systems in general while decreasing consequent medical visits in this group of patients.

trial registrationRegistered at German Clinical Trial Register (ID: DRKS00025960 and DRKS00026092).

Indexed as

Cancer SurvivorsNeoplasmsAdolescentCaregiversChildHumansLong-Term CareSurvivorsCancerCancer survivorshipFollow-up guidelinesFollow-up studiesInformal caregiversInsurance claims processingLate effectTransition to adult care

Identifiers

PMID36127717
PMCPMC9487026
OpenAlexW4296784262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.